Neal Shore, MD, FACS; Carolina Urologic Research Center 5Live #ASCO20
4:58
Key Insights on HERO phase III trial: Results comparing relugolix, an oral GnRH receptor antagonist, versus leuprolide acetate for advanced prostate cancer.
Prostate Cancer
Neal Shore, MD, FACS; Carolina Urologic Research Center 5Live #ASCO20
Key Insights on HERO phase III trial: Results comparing relugolix, an oral GnRH receptor antagonist, versus leuprolide acetate for advanced prostate cancer.
Prostate Cancer Similar Videos
Similar Videos
-
Expert Insights_New Treatments and New Targets for the Treatment of Prostate Cancer: Expanding Options Along the Disease Continuum
29:35
-
Advanced imaging in the modern era of prostate cancer_Ashesh Jani, MD, MSEE, FASTRO; #DDHO2021
2:54
-
Addressing Disparities in Cancer Care and Incorporating Precision Medicine for Minority Populations: Prostate Cancer_Arthur L. Burnett, MD, MBA, FACS_Yaw Nyame, MD.
50:53
